Wesley Yu
Physician · Sharp Healthcare
Credentials: · · · · ·
History
- 2026–Present
- 2019–2020
- 2015–2016
Preliminary or Transitional Year
Research
Warfarin-Associated Nonuremic Calciphylaxis
Case report · JAMA Dermatology · 2017 · First of 7 authors · 68 citations
Key binding interactions for memantine in the NMDA receptor
ACS Chemical Neuroscience · 2013 · 40 citations
Outcomes and Risk Factors in Patients with Multiple Primary Melanomas
Journal of Investigative Dermatology · 2019 · 19 citations
11 papers
- SL
6 papers
5 papers
5 papers · 4 as a resident
- AB
4 papers
- JV
4 papers
- JL
4 papers · 1 as a resident
4 papers
Grants
- 2024–2028
BOOST:Better Oncology Outcomes Through Statin Treatment
Department of Veterans Affairs · IK2
Contact PI · Portland Va Medical Center
Clinical trials
- 2024–2029
Principal investigator · Active not recruiting · Phase 2
OHSU Knight Cancer Institute
- 2020–2021
Tele-health Enabled Clinical Trial for COVID-19
Principal investigator · Withdrawn · Phase 1, Phase 2
University Hospitals Cleveland Medical Center
- 2018–2019
Treatment of Asian Flushing Syndrome With Topical Alpha Agonists
Principal investigator · Completed · Early phase 1
University of California, San Francisco